News

Photobiomodulation: Preventing and treating certain side effects of cancer treatments

A valuable asset in oncology, photobiomodulation or low-energy laser/LED therapy is used for its analgesic, anti-inflammatory, and healing properties. 

Published on

Photobiomodulation

A valuable asset in oncology, photobiomodulation or low-energy laser/LED therapy is used for its analgesic, anti-inflammatory, and healing properties. An innovative, non-invasive, and painless technique that promotes tolerance to chemotherapy and radiotherapy treatments.

Gustave Roussy has just acquired its fourth photobiomodulation device. The technique involves exposing cells or tissues to specific wavelengths of light to stimulate their activity.

Numerous indications in oncological supportive care

In oncology, photobiomodulation is used to help heal damaged tissues, improve immune response, reduce inflammation, and prevent or treat certain side effects of treatments such as chemotherapy and radiotherapy. Recommended for the prevention of mucositis (inflammation of the oral mucosa) and radiodermatitis (skin burns induced by radiotherapy), photobiomodulation is also the subject of recent clinical studies to expand its indications (peripheral neuropathies induced by certain chemotherapies, skin fibrosis, lymphedema, dry mouth or trismus). The technique is currently booming thanks to recent discoveries about its cellular mechanisms of action and progress in the setting of new devices.

This non-invasive method with no identified side effects to date has yielded proven clinical results in indications that have not benefited from any other therapeutic alternative.

→ More about

 

 

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin